TCG Crossover GP I, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for AN2 Therapeutics, Inc. Common Stock, $0.00001 par value (ANTX)

Filing Manager
TCG Crossover GP I, LLC
Reporting Manager
TCG Crossover GP I, LLC
Security
AN2 Therapeutics, Inc. Common Stock, $0.00001 par value
Symbol
ANTX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:44:44 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP I, LLC 0% 0 0 0 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund I, L.P. 0% 0 0 0 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 0% 0 0 0 /s/ Craig Skaling Craig Skaling, as attorney-in-fact for Chen Yu